Neudle.com: Parkinson disease progression

Differential
(Click to cross reference)

adolescent medicine

advances in neurology

adverse drug reaction

affect, flat

akathisia

alcohol, neurologic complications with

aphasia, progressive, primary

apraxia

apraxia, constructional

auditory and vestibular pathways

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autonomic cardiovascular reflexes

autonomic dysfunction

axonal degeneration

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

carbon monoxide poisoning

cardiomyopathy

CAT scan, emission, abnormal

cataplexy

cavernous hemangioma

central hypoventilation

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar edema

cerebellar lesion

cerebellitis

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, nonarterial territory

children

chorea

chromosomal abnormality

chromosome 19

cingulate island sign

cirrhosis

climate change

Clinical Pathologic Conference(C.P.C.)

computers, medicine and

contractures, joint

controversies in neurology

corpus callosum, thinning

cortical blindness

cortical infarction

cortical-basal ganglionic degeneration

cough

degenerative diseases of CNS

delay in diagnosis

delusion

dementia

dementia, age at onset

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, presenile

dementia, rapidly progressive

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diabetes mellitus

diagnostic criteria

differential diagnosis

diplopia

disorientation

distal muscle atrophy

diurnal variation

dopa responsive dystonia

dopamine agonist

drug induced neurologic disorders

encephalitis, episodic

encephalitis, Powassan

encephalitis, viral

encephalopathy

encephalopathy, delayed

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

erectile dysfunction

evidence-based research

executive dysfunction

exome sequencing

eye movement, disorders of

fourth ventricle, compression

frontal behavioral spatial syndrome

frontotemporal dementia, behavioral variant

gait disorder

galactorrhea

gammaglobulin therapy, intravenous

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

glutamic acid decarboxylase, antibody

grasp reflex

Hallervorden Spatz disease

hallucination

headache

hearing loss

hemangioma, brainstem

hepatolenticular degeneration, non-Wilsonian

hyperammonemic encephalopathy

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

iatrogenic neurologic disorders

inclusion bodies, intranuclear

incontinence, fecal

inflexibility, mental

insect sting

insomnia

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

L-dopa

leg spasms, painful

lenticular nucleus, lesion of, bilateral

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

malformation, vascular

malformation, vascular, cerebral

marche a petits pas

masked facies

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningoencephalitis

mental status, abnormal

micrographia

miglustat

migratory lesion pattern

mimics

misdiagnosis

mitochondrial disease

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal intensity of basal ganglia

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple system atrophy

neurodegeneration with brain iron accumulation

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic testing

neuronal intranuclear inclusion disease

neuronopathy

neuronopathy, sensory

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

neuroprotective agents

New England

Niemann-Pick disease

numbness, extremity

obsessive-compulsive disorder

ocular motility, disorders of

old age, neurology of

ophthalmoplegia, progressive external

organomegaly

orthostatic hypotension

pain, increased response

Parkinson disease, atypical

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

pathology

patient information and support

personality change

Pick bodies

Pick's disease

pleocytosis of cerebrospinal fluid

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

psychiatric problems in neurologic disorders

psychomotor retardation

pyramidal tract dysfunction

recurrent

Red flags

release phenomena

respirations in CNS disease

salivation, excessive

seizure, laughing as manifestation

selective serotonin reuptake inhibitors

serologic testing

shoulder, pain in

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

smell

SNCA duplication

speech disorder

speech disorder, childhood

stimulation, deep brain

striatonigral degeneration

temporal lobe, atrophy

tick bite

tick-borne encephalitis

toe walking

tonic foot response

treatment of neurologic disorder

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness

weakness, progressive

weight loss

wheelchair

white matter disease

whole genome sequencing

wide based gait

Wolff-Parkinson-White syndrome

word-finding difficulty

workup

Showing articles 1200 to 1250 of 2059 << Previous Next >>

Manganese Toxicity in Children Receiving Long-Term Parental Nutrition
Lancet 347:1218-1221, Fell,J.M.E.,et al, 1996

Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996

Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Survival & Prolif of Nonneural Tissu, with Obstr of Cereb Ventric, In Parkinson Pt Trt with Fetal Allografts
Neurol 46:1219-1225, Folkerth,R.D.&Durso,R., 1996

Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Gamma Knife Pallidotomy in Advanced Parkinson's Disease
Ann Neurol 39:535-538, Friedman,J.H.,et al, 1996

Diet and Parkinson's Diseae I:A Possible Role for the Past Intake of Specific Foods and Food Groups
Neurol 47:636-643, Hellenbrand,W.,et al, 1996

Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996

Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996

Transient Hemiballism/Hemichorea Dur to an Ipsilateral Subthalamic Nucleus Infarction
Neurol 46:267-268, Crozier,S.,et al, 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995

MRI In Patients with Suspected Vascular Parkinsonism
Neurol 45:2183-2188, Jijlmans,J.C.M.,et al, 1995

Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995

Effect of GPi Pallidotomy on Motor Function in Parkinson's Disease
Lancet 346:1383-1387, Lozano,A.M.,et al, 1995

Clinical and[18F]dopa PET Findings in Early Parkinson's Disease
JNNP 59:597-600, Morrish,P.K.,et al, 1995

Generalized Mitochondrial Dysfunction in Parkinson's Disease Detected by Magnetic Resonance Spectroscopy of Muscle
Neurol 45:2097-2099, Penn,A.M.W.,et al, 1995

Decreased SPECT[123I]B-CIT Striatal Uptake Correlates with Symptom Severity in Parkinson's Disease
Ann Neurol 38:589-598, Seibyl,J.P.,et al, 1995

Acute Fatal Deterioration in Putaminal Hemorrhage
Stroke 26:1953-1955, Wijdicks,E.F.M.&Fulgham,J.R., 1995

Measurement of Infarct Size Using MRI Predicts Prognosis in Middle Cerbral Artery Infarction
Stroke 26:2272-2276, Saunders,D.E.,et al, 1995

Ten Year Cerebrovascular Morbidity and Mortality in 68 Year Old Men with Asymptomatic Carotid Stenosis
BMJ 310:294-298, Ogren,M.,et al, 1995

Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995

Exacerbation of Idiopathic Parkinson's Disease by Naproxen
BMJ 311:422, Shaunak,S.,et al, 1995

Encephalopathy with Parkinsonian Features in Children Following Bone Marrow Transplantations and High-Dose Amphotericin B
Ann Neurol 37:810-814, Mott,S.H.,et al, 1995

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Kindreds of Dominantly Inherited Parkinson's Disease:Keys to the Riddle
Ann Neurol 38:355-356, Duvoisin,R.C.&Golbe,L.I., 1995

A Greek-American Kindred with Autosomal Dominant, Levodopa-Responsive Parkinsonism and Anticipation
Ann Neurol 38:373-378, 3551995., Markopoulou,K.,et al, 1995

Cigarette Smoking and Protection from Parkinson's Disease:False Association or Etiologic Clue?
Neurol 45:1041-1051, Morens,D.M.,et al, 1995

Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995

Neuropath Evid of Graft Survival & Striatal Reinnerva after Transpl of Fetal Mesencephalic Tissue in Parkinson's Dis
NEJM 332:1118-1124, 11631995., Kordower,J.H.,et al, 1995

Bilateral Fetal Nigral Transplantation Into the Postcommissural Putamen in Parkinson's Disease
Ann Neurol 38:379-388, Freemen,T.B.,et al, 1995

Stereotactic Ventral Pallidotomy for Parkinson's Disease
Neurol 45:753-761, Dogali,M.,et al, 1995

Electroconvulsive Therapy for the Physical Signs of Parkinson's Disease Without Depressive Disorder
JNNP 58:641-642, Pridmore,S.,et al, 1995

Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995

Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995

Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995

Risk Factors for Impaired Outcome after Spontaneous Intracerebral Hemorrhage
Arch Neurol 52:1193-1200, Juvela,S., 1995

A 79-Year Old Musician with Asymptomatic Carotid Artery Disease
JAMA 274:1383-1389, Caplan,L.R., 1995

Neurological and Functional Outcome in Patients with Supratentorial Hemorrhages:A Prospective Study
Stroke 26:2249-2253, Lampl,Y.,et al, 1995

Impact of Thalamic Hematoma on Six-Month Mortality and Motor and Cognitive Functional Outcome
Stroke 26:620-626, Mori,S.,et al, 1995

Thalamic Hemorrhage:A Prospective Study of 100 Patients
Stroke 26:964-970, Kumral,E.,et al, 1995

Hemiballismus:CT and MR Findings
J Comput Assist Tomogr 19:537-540, Provenzale,J.M.&Glass,J.P., 1995

Early Reperfusion in the'Spectacular Shrinking Deficit'Demonstr by SPECT
Neurol 45:1335-1339, Baird,A.E.,et al, 1995

Early Prediction of Stroke Severity:Role of the Erythrocyte Sedimentation Rate
Stroke 26:573-576, Chamorro,A.,et al, 1995

Showing articles 1200 to 1250 of 2059 << Previous Next >>